Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients
Open Access
- 16 January 2017
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Cancer
- Vol. 36 (1) , 1-7
Abstract
Chemotherapy toxicity is a serious problem from which non-small cell lung cancer (NSCLC) patients suffer. The mismatch repair (MMR) system is associated with platinum-based chemotherapy toxicity in NSCLC patients. In this study, we aimed to investigate the relationship between genetic polymorphisms in the MMR pathway and platinum-based chemotherapy toxicity in NSCLC patients. A total of 220 Chinese lung cancer patients who received at least two cycles of platinum-based chemotherapy were recruited for this study. Toxicity was evaluated in each patient after two cycles of chemotherapy. A total of 44 single nucleotide polymorphisms were selected to investigate their associations with platinum-based chemotherapy toxicity. MutS homolog 2 (MSH2) rs6544991 [odds ratio (OR) 2.98, 95% confidence interval (CI) 1.20–7.40, P = 0.019] was associated with gastrointestinal toxicity in the dominant model; MSH3 rs6151627 (OR 2.38, 95% CI 1.23–4.60, P = 0.010), rs6151670 (OR 2.05, 95% CI 1.07–3.93, P = 0.031), and rs7709909 (OR 2.38, 95% CI 1.23–4.64, P = 0.010) were associated with hematologic toxicity in the dominant model. Additionally, MSH5 rs805304 was significantly associated with overall toxicity (OR 2.21, 95% CI 1.19–4.09, P = 0.012), and MSH5 rs707939 was significantly associated with both overall toxicity (OR 0.42, 95% CI 0.23–0.76, P = 0.004) and gastrointestinal toxicity (OR 0.44, 95% CI 0.20–0.96, P = 0.038) in the dominant model. Genetic polymorphisms in the MMR pathway are potential clinical markers for predicting chemotherapy toxicity in NSCLC patients.Keywords
Funding Information
- National Natural Science Foundation of China (81173129, 81373490, 81273595)
- National Natural Science Foundation of China (CN) (81573463)
- Hunan Provincial Natural Science Foundation of China Grant (2015JJ1024)
This publication has 32 references indexed in Scilit:
- Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patientsEuropean Journal of Cancer, 2016
- Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)Lung Cancer, 2015
- The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patientsClinical and Translational Oncology, 2015
- Maintenance therapy in non-small cell lung cancerExpert Review of Anticancer Therapy, 2015
- Medical management of lung cancer: Experience in ChinaThoracic Cancer, 2015
- Correlation of MSH3 polymorphisms with response and survival in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapyGenetics and Molecular Research, 2015
- WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer PatientsInternational Journal of Molecular Sciences, 2014
- DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial2013
- A single amino acid substitution in MSH5 results in DNA alkylation toleranceGene, 2003
- Deficient DNA mismatch repair: a common etiologic factor for colon cancerHuman Molecular Genetics, 2001